secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K/A
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001628280-26-031642
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD appoints Vitor Roque as EVP and CFO effective May 7; compensation disclosed
------------------------------------------------------------------------------

- Roque named EVP and CFO effective May 7, 2026; served as interim CFO since December 2025.
- Annual base salary $770,000; target bonus 95% of base; annual equity target $3M.
- One-time cash award $250,000 and time-vested units $250,000 for interim service.
- Severance agreement: 2x salary and bonus upon change of control, two-year term.
- Roque led separation of Biosciences & Diagnostic Solutions ahead of schedule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000162828026031642/0001628280-26-031642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000162828026031642/bdx-20251009.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-031642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer